about
Pancreatic Cancer GeneticsRegulation of MYC gene expression by aberrant Wnt/β-catenin signaling in colorectal cancerNon-coding landscapes of colorectal cancerMYC, Metabolism, and CancerEpidemiology and Inherited Predisposition for Sporadic Pancreatic AdenocarcinomaDistinct lymphocyte antigens 6 (Ly6) family members Ly6D, Ly6E, Ly6K and Ly6H drive tumorigenesis and clinical outcomeUnderstanding inherited genetic risk of adult glioma - a reviewMYC Deregulation in Primary Human Cancers.Genome-wide association study identifies multiple susceptibility loci for pancreatic cancer.Role of non-coding sequence variants in cancer.Can genome engineering be used to target cancer-associated enhancers?Prognostic relevance of urinary bladder cancer susceptibility loci.A genome-wide pleiotropy scan for prostate cancer risk.Prostate cancer risk alleles and their associations with other malignancies.Replication study for the association of seven genome- GWAS-identified Loci with susceptibility to ovarian cancer in the Polish population.Genome-wide expression and copy number analysis identifies driver genes in gingivobuccal cancersThe 8q24 gene desert: an oasis of non-coding transcriptional activity.Regulators of gene expression as biomarkers for prostate cancerOverexpression of CTNND1 in hepatocellular carcinoma promotes carcinous characters through activation of Wnt/β-catenin signalingA genome-wide association study of severe teenage acne in European AmericansVariants at IRX4 as prostate cancer expression quantitative trait loci.Enigmatic MYC Conducts an Unfolding Systems Biology Symphony.Enhancer deregulation in cancer and other diseases.Interactions Between Genome-Wide Significant Genetic Variants and Circulating Concentrations of 25-Hydroxyvitamin D in Relation to Prostate Cancer Risk in the National Cancer Institute BPC3.Anti-proliferative effects of polyphenols from pomegranate rind (Punica granatum L.) on EJ bladder cancer cells via regulation of p53/miR-34a axis.Involvement of Non-coding RNAs in the Signaling Pathways of Colorectal Cancer.Enhancer-targeted genome editing selectively blocks innate resistance to oncokinase inhibition.CCAT1 and CCAT2 long noncoding RNAs, located within the 8q.24.21 'gene desert', serve as important prognostic biomarkers in colorectal cancer.Fine-scale mapping of 8q24 locus identifies multiple independent risk variants for breast cancer.Correlation Between CASC8, SMAD7 Polymorphisms and the Susceptibility to Colorectal Cancer: An Updated Meta-Analysis Based on GWAS Results.Atypical rearrangement involving 3'-IGH@ and a breakpoint at least 400 Kb upstream of an intact MYC in a CLL patient with an apparently balanced t(8;14)(q24.1;q32) and negative MYC expression.Characterization of the genotype and integration patterns of hepatitis B virus in early- and late-onset hepatocellular carcinoma.Long non-coding RNA CCAT1 is overexpressed in oral squamous cell carcinomas and predicts poor prognosis.Breast cancer: The translation of big genomic data to cancer precision medicine.Somatic Superenhancer Duplications and Hotspot Mutations Lead to Oncogenic Activation of the KLF5 Transcription Factor.Cross-Phenotype Association Analysis Using Summary Statistics from GWAS.The potential use of lncRNAs found in the 8q24 region as biomarkers for colon cancer.Autotaxin in Pathophysiology and Pulmonary Fibrosis.Non-coding genetic variation in cancer
P2860
Q26765235-4FCFCE09-C6AE-4DA2-B947-0CD4C67D76A5Q26775423-D94CF7B8-39D3-4F15-A5F1-42B8F17E96FBQ26778014-877F88E7-78CE-4EEB-A444-B558C0A56D9AQ26783555-FCE8841B-0EA8-4F14-BA28-096E9EFD8C4FQ26801418-AB24AAE2-B0A2-40AC-A3AE-219CB894735BQ28273187-B09266CE-367D-4050-9CEA-7149D10B4EA5Q28388566-23DDB070-34AA-44F0-B12B-E67A8A94788CQ33836755-6457637C-BB07-42B3-B5C8-DC3D49F7C30FQ34314018-692651AD-7662-4DCC-B3C2-F4E35F9FC375Q34509633-86F4101A-B191-44E2-8B84-2DFB0A373659Q34652242-C10A3FC6-7F84-437B-9F3D-0A7C7B503CBCQ35106772-0A481A2D-4716-4387-A063-77A41DFBDEFDQ35177444-0226D136-585C-403A-8E5E-EA27E0474092Q35300437-BD2D963B-6082-4532-941E-C51C86E23D80Q35578071-9B3714AE-3E3E-4BB2-8598-0B9C58410CF6Q35600924-1B5887F3-5AA2-4F98-943D-E35D5F4E2506Q35919877-5FC789E4-C996-4A8E-816E-70F271281F17Q36439912-F3C93DB3-791F-436B-AB59-14718B7E2066Q36915235-E8AFFEAC-8876-4B8A-A628-5EA2FD058E94Q37623334-A0B8E214-BC5A-4C31-BDE2-8C4310C7272BQ37636770-A539EECD-DA25-4298-8D26-45F9A54FBCF5Q37827073-8D73793D-5D13-4DC9-8DF6-CADAF371099FQ38826989-ACFF784E-AD4D-4E24-A333-63AC96F9291BQ38842066-D0237725-E6D5-4D00-A17C-6AA32990B97BQ38921935-BA1E0A7F-7676-4209-A000-C20F582E20F0Q38940586-49A0DC01-5AE0-4C99-B832-AC91C89A7022Q39032842-56D9CE9B-9377-4188-AC8C-D0E8534CAA5FQ39332384-46F1D5CF-98FA-41AF-BF25-98FCBA7C2E57Q39844032-2E2C946F-D7D5-4080-84B2-3CA351641715Q40309206-A2B5C26D-9E24-486D-84FD-DBC45BCBE921Q41055702-CC658749-B561-40D3-B0B4-8A3DC6ACEC8BQ41518564-43C52318-DA8F-49FF-BD42-67F5D63103F8Q42177374-2FF2B90C-814A-4A60-971A-48C447625724Q45943221-8DCA9D83-3851-402E-8296-2701AED0BFD2Q47723106-8011848E-3442-46F5-BC24-1654FA321937Q49587994-8A15CA22-44FD-4F15-81F9-EC52D0E03D8CQ52758032-830A2461-79BB-40D0-A733-4D49C19ED633Q55420502-7984A271-DEA7-432B-8E34-8C2C66236E86Q58134002-BDB64F63-123B-449E-9B75-0FED024472F8
P2860
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Chromosome 8q24-Associated Cancers and MYC.
@ast
Chromosome 8q24-Associated Cancers and MYC.
@en
Chromosome 8q24-Associated Cancers and MYC.
@nl
type
label
Chromosome 8q24-Associated Cancers and MYC.
@ast
Chromosome 8q24-Associated Cancers and MYC.
@en
Chromosome 8q24-Associated Cancers and MYC.
@nl
prefLabel
Chromosome 8q24-Associated Cancers and MYC.
@ast
Chromosome 8q24-Associated Cancers and MYC.
@en
Chromosome 8q24-Associated Cancers and MYC.
@nl
P2860
P356
P1433
P1476
Chromosome 8q24-Associated Cancers and MYC.
@en
P2093
Chiara Grisanzio
Matthew L Freedman
P2860
P304
P356
10.1177/1947601910381380
P577
2010-06-01T00:00:00Z